Axiobionics, LLC

Axiobionics develops and markets wearable electrical muscle stimulation systems for chronic pain management, mobility restoration, and muscle paralysis recovery. The company's primary product portfolio includes the BioSleeve (upper extremity muscle stimulation for hemiplegia, stroke, traumatic brain injury, and cerebral palsy), BioBelt (lower back pain and spasm alleviation), BioShort (lower extremity and pain management), and MyoPro (arm function restoration). These FDA-cleared, non-invasive wearable devices deliver gentle electrical impulses to stimulate muscles during daily activities, addressing conditions including spinal cord injury, stroke, multiple sclerosis, foot drop, and chronic pain. The company reports over 10,000 systems sold globally and cites a peer-reviewed 10-year longitudinal study demonstrating 5.5% average annual improvement in arm usage for hemiplegia patients. Axiobionics serves patients across rehabilitation, pain management, and neurological recovery markets, with a focus on enabling daily-wear therapy outside clinical settings. The organization positions itself as a long-term care partner, offering consultation and ongoing support for neurological and musculoskeletal conditions.